%0 Journal Article %A Shan Wei %A Esther Kohl %A Alexandre Djandji %A Stephanie Morgan %A Susan Whittier %A Mahesh Mansukhani %A Eldad Hod %A Mary D’Alton %A Yousin Suh %A Zev Williams %T Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction %D 2020 %R 10.1101/2020.05.28.20115220 %J medRxiv %P 2020.05.28.20115220 %X The COVID-19 pandemic has resulted in an urgent global need for rapid, point-of-care diagnostic testing. Existing methods for nucleic acid amplification testing (NAAT) require an RNA extraction step prior to amplification of the viral RNA. This step necessitates the use of a centralized laboratory or complex and costly proprietary cartridges and equipment, and thereby prevents low-cost, scalable, point-of-care testing. We report the development of a highly sensitive and robust, easy-to-implement, SARS-CoV-2 test that utilizes isothermal amplification and can be run directly on viral transport media following a nasopharyngeal swab without the need for prior RNA extraction. Our assay provides visual results in 30 min with 85% sensitivity, 100% specificity, and a limit of detection (LoD) of 2.5 copies/μl, and can be run using a simple heat block.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is supported by NIH grants R01HD100013 (Z.W.), R01HD086327 (Z.W.), 1RF1AG057341 (Y.S), and R01AG057433 (Y.S).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and approved by the Institutional Review Board of Columbia University Medical Center (Protocol# AAAS9910).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo sequencing data is generated in this study. Data referred to is available upon request. %U https://www.medrxiv.org/content/medrxiv/early/2020/06/02/2020.05.28.20115220.full.pdf